Literature DB >> 14746357

Survival of U.S. Black and White patients with squamous cell cancer of the esophagus.

Anthony P Polednak1.   

Abstract

Using data from 11 population-based cancer registries on 1,125 black and 2,392 white patients diagnosed with squamous cell carcinoma of the esophagus in 1992-1998, black-white differences in the relative survival rate (RSR)-which adjusts for mortality in the general population-were large only for localized-stage cancer. Within localized stage, black-white differences in RSR were smaller among patients without pathologic review of regional lymph nodes (RLNs). The low frequency of pathologic review of lymph nodes (8% of blacks and 12% of whites) among patients coded as "localized stage" indicates that staging was based on clinical tests (not recorded in cancer registries) and cancer-directed surgery (which was less frequent in blacks than whites). In Cox proportional hazards regression models, including cancer-directed surgery, along with demographic characteristics, the relative risk of death (hazard ratio) for all blacks versus whites was only 1.13 for all stages but 1.31 in a model with only localized-stage patients. Studies are needed on the extent of radiographic, endoscopic and other techniques used to assess stage in black versus white patients. The low survival rates for both blacks and whites emphasize the need for improved treatment and primary prevention efforts.

Entities:  

Mesh:

Year:  2004        PMID: 14746357      PMCID: PMC2594760     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  Race and outcomes: is this the end of the beginning for minority health research?

Authors:  O W Brawley; H P Freeman
Journal:  J Natl Cancer Inst       Date:  1999-11-17       Impact factor: 13.506

Review 2.  Racial and ethnic disparities in the receipt of cancer treatment.

Authors:  Vickie L Shavers; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

3.  Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas.

Authors:  Anthony P Polednak
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

4.  Surgical treatment of esophageal cancer--the advent of the era of individualization.

Authors:  Masaki Kitajima; Yuko Kitagawa
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

5.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.

Authors:  D P Kelsen; R Ginsberg; T F Pajak; D G Sheahan; L Gunderson; J Mortimer; N Estes; D G Haller; J Ajani; W Kocha; B D Minsky; J A Roth
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

6.  Survival of blacks and whites after a cancer diagnosis.

Authors:  Peter B Bach; Deborah Schrag; Otis W Brawley; Aaron Galaznik; Sofia Yakren; Colin B Begg
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

7.  Are increasing 5-year survival rates evidence of success against cancer?

Authors:  H G Welch; L M Schwartz; S Woloshin
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

8.  Determinants of black/white differences in colon cancer survival.

Authors:  R M Mayberry; R J Coates; H A Hill; L A Click; V W Chen; D F Austin; C K Redmond; C M Fenoglio-Preiser; C P Hunter; M A Haynes
Journal:  J Natl Cancer Inst       Date:  1995-11-15       Impact factor: 13.506

9.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.

Authors:  S S Devesa; W J Blot; J F Fraumeni
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

10.  Radiation therapy for esophageal cancer: the Medical College of Virginia experience.

Authors:  B Amendola; T A Hazra; R Belgrad; E R King
Journal:  South Med J       Date:  1980-11       Impact factor: 0.954

View more
  1 in total

1.  Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013.

Authors:  Alice Kim; Peter Ashman; Melissa Ward-Peterson; Juan Manuel Lozano; Noël C Barengo
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.